Artax Biopharma Inc

📍 Cambridge, United States🗓 Founded 2013👥 14 employees💰 Last funded Feb 2017
Biotechnology Research🌐 artaxbiopharma.com
Website LinkedIn
Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T cell activation. Specific control over T cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2013
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Spain
2
United States
1
Investor activity2013–2017 · investors recorded per year
201312014120171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Artax Biopharma Inc?
Artax Biopharma Inc has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Artax Biopharma Inc last raise funding?
The most recent investment in Artax Biopharma Inc recorded on gritt.io was in February 2017.
When was Artax Biopharma Inc founded?
Artax Biopharma Inc was founded in 2013.
What industry is Artax Biopharma Inc in?
Artax Biopharma Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Artax Biopharma Inc based?
Artax Biopharma Inc is headquartered in Cambridge, United States.